[Retracted] Synergistic Effect of Stereotactic Radiotherapy Combined with Karelizumab on Patients with Advanced NSCLC

Table 2

Comparison of treatment effect between two groups (n, %).

Groups	CR	PR	SD	PD	Total effective rate
Control group (n = 54)	0 (0.00%)	15 (27.78%)	20 (37.03%)	19 (35.19%)	15 (27.78%)
Observation group (n = 46)	0 (0.00%)	23 (50.00%)	15 (32.61%)	8 (17.39%)	23 (50.00%)
χ^2					5.206
P value					0.022